0

Global Chemotherapy Treatment Market 2019-2023

  • Published: May 2019
  • Pages: 136
  • SKU: IRTNTR31249
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The global chemotherapy treatment market will grow by USD 3.99 billion during 2019-2023. The chemotherapy market report provides a detailed analysis of the market by drug class (antimetabolites, plant derivatives, cytotoxic antibiotics, alkylating agents, and others) and geography (Asia, Europe, North America, and ROW). The report analyzes the market’s competitive landscape and offers information on several chemotherapy treatment drug manufacturers including Bristol-Myers Squibb Co., Eli Lilly and Co., Johnson & Johnson Services Inc., Novartis AG, and Pfizer Inc.

To identify growth opportunities in the chemotherapy treatment market, the market has been segmented into regions that are growing faster than the overall market. These regions have been pitted against regions that have a slower growth rate than the global market in 2019-2023. Europe and North America will grow faster than the overall market. Asia and ROW’s growth will be slower than the global market.

Some of the key findings from our chemotherapy treatment market forecast report are summarized below

Chemotherapy Treatment Market

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from the chemotherapy treatment market report.

Get a FREE sample now!

Global chemotherapy treatment industry overview

Chemotherapy drugs cause several side effects such as peripheral neuropathy, vomiting and nausea, hypersensitivity reactions, neutropenia, and gastrointestinal side effects. This has led to the development of several drugs to counter these side-effects. Antiemetics such as palonosetron, dolasetron, granisetron, and tropisetron are used to treat chemotherapy-induced vomiting and nausea. Similarly, colony-stimulating factor (agents) such as filgrastim and pegfilgrastim are used to treat neutropenia and stimulate the production of neutrophils from the bone marrow. The availability of such drugs to treat chemotherapy-induced side effects is expected to drive the growth of the chemotherapy treatment market during the forecast period.

The increase in drug resistance has led to the development of combination therapies. Combination therapy has the potential to reduce drug resistance as tumors are expected to have less resistance to multiple drugs. Many vendors are developing combination therapies with chemotherapy drugs besides targeted therapies. Most of the combination therapy drugs are currently in Phase III of clinical trials and is expected to receive marketing approval over the forecast period. The development of combination therapies is one of the key trends that will fuel the growth of the chemotherapy treatment market at a CAGR of nearly 3% during the forecast period.

Top companies covered in the chemotherapy treatment market research report

The global chemotherapy treatment market is fairly concentrated. To help clients improve their revenue share, the chemotherapy market research report provides an analysis of the market's competitive landscape and offers information on the products offered by various leading companies. Key insights provided in the chemotherapy market analysis report will help companies make informed business decisions.

The report offers a detailed analysis of several leading companies, including:

  • Bristol-Myers Squibb Co.
  • Eli Lilly and Co.
  • Johnson & Johnson Services Inc.
  • Novartis AG
  • Pfizer Inc.

Chemotherapy treatment market segmentation based on drug class

  • Antimetabolites
  • Plant derivatives
  • Cytotoxic antibiotics
  • Alkylating agents
  • Others

The antimetabolites segment will account for the largest global chemotherapy treatment market share during the forecast period. Antimetabolite such as methotrexate are commonly used as a chemotherapeutic agent to treat patients with breast, colon, bladder, and head and cancers. Similarly, gemcitabine is an antimetabolite that is found to be active against solid tumors and is less expected to cause myelosuppression. Such chemotherapeutic properties offered by antimetabolites is driving the growth of the chemotherapy treatment market in this segment.

Chemotherapy treatment market segmentation based on geography

  • Asia
  • Europe
  • North America
  • ROW

North America is the largest geographical segment of the global chemotherapy treatment market. The chemotherapy market in North America is driven by the growing prevalence of cancer in the US. The strong presence of global vendors in the region and the availability of chemotherapeutics is contributing to the growth of the market. Also, the approval of combination therapies that are in the late stages of clinical trials is expected to drive the chemotherapy treatment market in North America.

Key highlights of the global chemotherapy treatment market for the forecast years 2019-2023:

  • CAGR of the market during the forecast period 2019-2023
  • Detailed information on factors that will accelerate the growth of the chemotherapy market during the next five years
  • Precise estimation of the global chemotherapy treatment market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the chemotherapy treatment industry across Asia, Europe, North America, and ROW
  • A thorough analysis of the market's competitive landscape and detailed information on several vendors
  • Comprehensive details of factors that will challenge the growth of chemotherapy treatment companies  

We can help! Our analysts can customize the chemotherapy treatment market market research report to meet your requirements. Get in touch

 

Read More Read Less

PART 01: EXECUTIVE SUMMARY              

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY DRUG CLASS

  • Market segmentation by drug class
  • Comparison by drug class
  • Antimetabolites - Market size and forecast 2018-2023
  • Plant derivatives - Market size and forecast 2018-2023
  • Cytotoxic antibiotics - Market size and forecast 2018-2023
  • Alkylating agents - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by drug class

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Market trends

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bristol-Myers Squibb Co.
  • Eli Lilly and Co.
  • Johnson & Johnson Services Inc.
  • Novartis AG
  • Pfizer Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of vendors classification

PART 15: EXPLORE TECHNAVIO

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Technavio
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Reports 2019
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>